Oxford-AstraZeneca

First ‘Phase’ Of Covid-19 Vaccination To Inoculate 30 Crore Indians

About 30 crore people will be part of the first “wave” to get the Covid-19 vaccine in India. They consist of health care workers, police personnel, those above 50, and…

View Post

Covid-19 Vaccine: Oxford-AstraZeneca Covid-19 Vaccine Up To 90% Effective in Late-Stage Trials

AstraZeneca said on Monday its vaccine for the novel coronavirus, developed along with the University of Oxford, could be around 90% effective under one dosing regimen. “Today marks an important…

View Post

Covishield Vaccine: India May Get Oxford Shots In January; Might Be Priced Between Rs 500-600

The Pune-based vaccine manufacturer Serum Institute of India (SII) is hoping that the final results of the ongoing clinical trials of the Covid-19 vaccine candidate Covishield will be out by…

View Post

Coronavirus Vaccine: After Pfizer Trial Success, Check Out The Status Of Other Leading Candidates

Amid the race to develop a ‘potential’ vaccine against novel coronavirus pandemic, Pfizer says an early peek at its vaccine data suggests the shots maybe 90 percent effective at preventing…

View Post

Menu

Oxford-AstraZeneca

First ‘Phase’ Of Covid-19 Vaccination To Inoculate 30 Crore Indians

Covid-19 Vaccine: Oxford-AstraZeneca Covid-19 Vaccine Up To 90% Effective in Late-Stage Trials

Covishield Vaccine: India May Get Oxford Shots In January; Might Be Priced Between Rs 500-600

Coronavirus Vaccine: After Pfizer Trial Success, Check Out The Status Of Other Leading Candidates

Heart Muscle Regeneration Observed in Patients with Artificial Hearts, Study Finds

Flesh-Eating Ulcer Cases Surge in Australia: Health Authorities Issue Warning

Epigamia Co-Founder Rohan Mirchandani Passes Away at 42 Due to Cardiac Arrest: Key Risk Factors and Warning Signs for Men in Their 40s

Does the 2022 H5N1 Virus Bind and Replicate Better in the Human Respiratory Tract? Here’s The Truth

Walking Speed Is An Indicator of Metabolic Health in Obese Individuals: Study Reveals

First-Ever Blood-Stage Malaria Vaccine Shows Promising Results in Phase IIb Trial

FDA Moves to Restrict Psychoactive Mushrooms Used in Edibles Amid Growing Concerns

Revolutionary CAR-T Cell Therapy Developed by AIIMS Researchers Offers New Hope for Multiple Myeloma Patients